Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 460 (2) , 130-132
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Immunology of Multiple SclerosisSeminars in Neurology, 2008
- Immune cell BDNF secretion is associated with white matter volume in multiple sclerosisJournal of Neuroimmunology, 2007
- Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobulinsMultiple Sclerosis Journal, 2007
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006
- Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetateJournal of Neuroimmunology, 2005
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?Brain, 2002
- Neurotrophins as synaptic modulatorsNature Reviews Neuroscience, 2001
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Rating neurologic impairment in multiple sclerosisNeurology, 1983